Navigation Links
Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results
Date:2/29/2008

hts* (20,000) (1,150)

Branded License Fees and Premium

Paid on Equity Investments 19,150 -

Stock Option Tender Offer 4,615 -

Severance Costs 1,643 12,373

Net Investment Loss 1,584 583

Gain on Settlement (578) 1,502

Write-off of Accounts Receivable

Relating to Invalid

Customer Deductions - 9,965

Asset Impairment - 1,000

Estimated Tax on Adjustments (2,437) (9,466)

Adjusted Income from Continuing

Operations (non-GAAP measure) $55,087 $21,548

Diluted Earning Per Share from

Continuing Operations:

Reported $1.47 $0.19

Adjusted (non-GAAP measure) $1.59 $0.62

*2006 amounts represent $3,054 gain on sale of product rights net of $1,904 loss on the return of inventory from a customer relating to the same agreement.


'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, March 3, 2008
2. China Sky One Medical, Inc. to Acquire Heilongjiang Tianlong Pharmaceutical, Inc.
3. MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results
4. KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis
5. Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
6. Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference
7. VIA Pharmaceuticals to Present at Susquehanna and Rodman & Renshaw Conferences on March 4, 2008
8. Lotus Pharmaceuticals Raises $5 Million in Private Placement
9. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
10. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
11. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...nimally-invasive procedures that provide patients ...k of sinusitis, or sinus infection, are being deve...oring Institute. Techniques such as balloon sinup...having to remove any bone or tissue like tradition...throughs in treating sinus symptoms were featured ...
(Date:11/25/2009)...wire/--Therearemanywaysyoucanimprove,yourhealth,an...waysseemstobeconflictingadviceconcerningwhatisgood...o,therealbuzz.comteamhascompiledalistof25health-bo...tible!Doingacombinationof,oursuggestedactivitieswi...eing-sotrythemout. , 1.Reduceyourfatintake.Th...
(Date:11/24/2009)...ercent of radiation oncologists use advanced imagi... (FDG-PET), magnetic resonance imaging (MRI), and ...t delineation (to locate the tumor and other areas...le in the December issue of the Journal of the Am...rg ). , In defining the target, the radiation on...
(Date:11/24/2009)...of Miami School of Medicine compared the outcomes ...nts for nonalcoholic steatohepatitis (NASH) versus...stically significant differences in post-transplan... Study findings are presented in the December issu...by Wiley-Blackwell on behalf of the American Assoc...
(Date:11/24/2009)...ton University School of Medicine (BUSM) and the B... have identified a number of proteins whose activa... normal cells with almost 97 percent accuracy. In ...computational strategy to analyze this data and sp...ular circuits) that are active in cancer and "dorm...
Breaking Medicine News(10 mins):Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 2Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 3Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 4Health News:realbuzz.com - Top 25 Ways to Improve Your Health & get a Better Sex Life! 2Health News:New data emerges on liver transplant survival rates 2Health News:New data emerges on liver transplant survival rates 3Health News:Researchers identify proteins in lung cancer cells that may provide potential drug targets 2
...covered that suffering from infection increases th...hich is a dangerous condition in which blood clots... That infection can cause an increase in the risk ... that infection can also cause DVT. Research...
...h HIV/AIDS have opposed a patent application filed...ir, a fixed dose combination AIDS drug on the grou... // Represented by the Lawyers' Collective ...tion to a patent application filed at the Kolkata ...
...ical Center and John Hopkins University School of ...aling pathway that plays a vital role in the embry...o injury lead to the development of liver cancer. ...rgeted treatment of liver cancer, which happens to...
... propagate a new method of sex education for young...vice president with the China Family Planning Asso... arrived earlier in recent years, but sex educatio...ar. Education on sex and reproductive health ...
... among city kids in Britain, increasing their susc...archers, only 37% of the urban kids really walk to...suburban areas. Nearly 47% of the kids spend almos...he above 40 age group. In Britain, more than ...
...ggests, that a pain killing medication helps by ha... common form of breast cancer. The name of the pai...iments on breast cancer cells, scientists found th...e most common breast cancer in postmenopausal wome...
Other Medicine News:Health News:HIV Patients Opposes Patenting Of AIDS Drug 2Health News:Unchecked Cellular Repair Pathway Causes Liver Cancer 2Health News:Pain-killer Drug Can Help Fight Breast Cancer 2
(Date:11/25/2009)...PRNewswire/--AccordingtoMillenniumResearchGroup(MR...lligence,thenearly$3billionUSmarketfortraumafixati...veyearsdespitetherecenteconomicslowdown.MRG,s USMa...ketwillremainhighlydynamicoverthenextfiveyears,wit...slyunderservedsegmentsofthetraumafixationmarket,fu...
(Date:11/25/2009)...wire/--Reportlinker.comannouncesthatanewmarketrese...asalDrugDelivery-USMarketTrends&Analysis http...elivery---US-Market-Trends--Analysis.html ,, T...nsionoftherapeuticapplicationsfromthedeliveryofcon...mictherapeuticdrugs.Thefutureofthetechnologyhinges...
(Date:11/24/2009)...RNewswire-Asia/--ChindexInternational,Inc.,("Chind...viderofWestern,healthcareproductsandservicesintheP...nywillattendthe21stAnnualPiperJaffray,"Unplugged"H...,NewYorkPalaceHotel. , Managementiscurrentlys...009,andholdone-on-onemeetingsthroughouttheday.Aweb...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2All Eyes on The Medical Home 3A Patient Centered Primary Care Collaborative Convenes National Summit In Washington DC 55867 1All Eyes on The Medical Home 3A Patient Centered Primary Care Collaborative Convenes National Summit In Washington DC 55867 2All Eyes on The Medical Home 3A Patient Centered Primary Care Collaborative Convenes National Summit In Washington DC 55867 3RJR Other Tobacco Companies Go to Court to Evade Regulation by FDA 55862 1RJR Other Tobacco Companies Go to Court to Evade Regulation by FDA 55862 2Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 1Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 2
...GO, June 21, 2007 /PRNewswire-FirstCall/ -- Advanc...positive results from,Trial CL-06, the first of tw...ss the safety and effectiveness of cethromycin, a,...community,acquired pneumonia (CAP). In the study, ...y endpoint of per protocol clinical,cure rate comp...
...NSHIRE, Ill.--(BUSINESS WIRE)--Jun 21, 2007 - BioS...ed comment on the,Women,s Health Initiative (WHI) ...in The New England Journal of Medicine (NEJM).,The...0-59) who,received a standard dose of estrogen the...ication at the end of the study period,compared wi...
Other Medicine Technology:Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 2Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 3Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 4Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 5New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 2New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 3New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 4
O.R. Special Procedure Apron
Special Procedure Apron
Easy Wrap Apron
Disposable Monopolar NeedleElectrodes With Detachable Lead Wire
Medicine Products: